{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T02:29:18.842635+00:00","published_at":"2026-10-16T13:53:16.622146+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:gnyyug1er0pk4","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:53:16.622146+00:00","subject_ids":["alpha:person:andrew-oxtoby","alpha:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c"],"caused_claim_ids":["alpha:claim:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064"],"summary":"Andrew Oxtoby seat on Kalaris Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:h5yyjh153atrz","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:53:16.622146+00:00","subject_ids":["alpha:person:anthony-p-adamis-m-d","alpha:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c"],"caused_claim_ids":["alpha:claim:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064"],"summary":"Anthony P. Adamis, M.D. seat on Kalaris Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1lhku3c1adiuam","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:53:16.622146+00:00","subject_ids":["alpha:person:leone-patterson","alpha:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c"],"caused_claim_ids":["alpha:claim:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064"],"summary":"Les Patterson seat on Kalaris Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1gtgsgtz0bpz3","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:53:16.622146+00:00","subject_ids":["alpha:person:michael-dybbs-ph-d","alpha:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c"],"caused_claim_ids":["alpha:claim:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064"],"summary":"Michael Dybbs, Ph.D. seat on Kalaris Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:i6tdcp6kpk3d","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:53:16.622146+00:00","subject_ids":["alpha:person:napoleone-ferrara-m-d","alpha:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c"],"caused_claim_ids":["alpha:claim:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064"],"summary":"Napoleone Ferrara, M.D. seat on Kalaris Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:qkyumq1try8jy","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:53:16.622146+00:00","subject_ids":["alpha:person:srinivas-akkaraju-m-d-ph-d","alpha:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c"],"caused_claim_ids":["alpha:claim:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064"],"summary":"Srinivas Akkaraju, M.D., Ph.D. seat on Kalaris Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:756pw8e0xcza","event_type":"COMMITTEE_CREATED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:53:16.622146+00:00","subject_ids":["alpha:committee:kalaris-therapeutics-inc:audit-chair","alpha:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c"],"caused_claim_ids":["alpha:claim:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064"],"summary":"Audit · Chair committee of Kalaris Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:maaxa6gvw97q","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:53:16.622146+00:00","subject_ids":["alpha:person:leone-patterson","alpha:committee:kalaris-therapeutics-inc:audit-chair"],"caused_claim_ids":["alpha:claim:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064"],"summary":"Les Patterson member of Audit · Chair, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:15y3j31gs04t3","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-16T13:53:16.622146+00:00","subject_ids":["alpha:person:morana-jovan-embiricos-ph-d","alpha:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c"],"caused_claim_ids":["alpha:claim:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064"],"summary":"Morana Jovan-Embiricos, Ph.D. seat on Kalaris Therapeutics, Inc., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1rdvm02ft1vjc","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-16T13:53:16.622146+00:00","subject_ids":["alpha:person:david-hallal","alpha:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c"],"caused_claim_ids":["alpha:claim:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064"],"summary":"David Hallal seat on Kalaris Therapeutics, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:96w9z033whd0","event_type":"COMMITTEE_CREATED","effective_at":"2018-01-01","detected_at":"2026-10-16T13:53:16.622146+00:00","subject_ids":["alpha:committee:kalaris-therapeutics-inc:compensation-nominating-and-governance","alpha:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c"],"caused_claim_ids":["alpha:claim:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064"],"summary":"Compensation; Nominating and Governance committee of Kalaris Therapeutics, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:141ke1jz3xprf","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2018-01-01","detected_at":"2026-10-16T13:53:16.622146+00:00","subject_ids":["alpha:person:david-hallal","alpha:committee:kalaris-therapeutics-inc:compensation-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064"],"summary":"David Hallal member of Compensation; Nominating and Governance, effective 2018-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c:leadership_role:7","subject_id":"alpha:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:andrew-oxtoby","object_label":"Andrew Oxtoby","object_source_name_forms":[],"value":"Andrew Oxtoby: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:andrew-oxtoby","name":"Andrew Oxtoby"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:16.622146+00:00","sources":[{"id":"alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Kalaris Therapeutics, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T23:29:01.172+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:16.622146+00:00","reviewed_at":"2026-10-16T13:53:16.622146+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c:leadership_role:8","subject_id":"alpha:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:anthony-p-adamis-m-d","object_label":"Anthony P. Adamis, M.D.","object_source_name_forms":[],"value":"Anthony P. Adamis, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:anthony-p-adamis-m-d","name":"Anthony P. Adamis, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:16.622146+00:00","sources":[{"id":"alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Kalaris Therapeutics, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T23:29:01.172+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:16.622146+00:00","reviewed_at":"2026-10-16T13:53:16.622146+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c:leadership_role:9","subject_id":"alpha:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-hallal","object_label":"David Hallal","object_source_name_forms":[],"value":"David Hallal: Director, Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:david-hallal","name":"David Hallal"},"title":"Director","role_category":"director","committee":"Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:16.622146+00:00","sources":[{"id":"alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Kalaris Therapeutics, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T23:29:01.172+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:16.622146+00:00","reviewed_at":"2026-10-16T13:53:16.622146+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c:leadership_role:10","subject_id":"alpha:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:leone-patterson","object_label":"Les Patterson","object_source_name_forms":[],"value":"Les Patterson: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:leone-patterson","name":"Les Patterson"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:16.622146+00:00","sources":[{"id":"alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Kalaris Therapeutics, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T23:29:01.172+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:16.622146+00:00","reviewed_at":"2026-10-16T13:53:16.622146+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c:leadership_role:11","subject_id":"alpha:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-dybbs-ph-d","object_label":"Michael Dybbs, Ph.D.","object_source_name_forms":[],"value":"Michael Dybbs, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-dybbs-ph-d","name":"Michael Dybbs, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:16.622146+00:00","sources":[{"id":"alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Kalaris Therapeutics, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T23:29:01.172+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:16.622146+00:00","reviewed_at":"2026-10-16T13:53:16.622146+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c:leadership_role:12","subject_id":"alpha:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:morana-jovan-embiricos-ph-d","object_label":"Morana Jovan-Embiricos, Ph.D.","object_source_name_forms":[],"value":"Morana Jovan-Embiricos, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:morana-jovan-embiricos-ph-d","name":"Morana Jovan-Embiricos, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:16.622146+00:00","sources":[{"id":"alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Kalaris Therapeutics, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T23:29:01.172+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:16.622146+00:00","reviewed_at":"2026-10-16T13:53:16.622146+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c:leadership_role:13","subject_id":"alpha:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:napoleone-ferrara-m-d","object_label":"Napoleone Ferrara, M.D.","object_source_name_forms":[],"value":"Napoleone Ferrara, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:napoleone-ferrara-m-d","name":"Napoleone Ferrara, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:16.622146+00:00","sources":[{"id":"alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Kalaris Therapeutics, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T23:29:01.172+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:16.622146+00:00","reviewed_at":"2026-10-16T13:53:16.622146+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c:leadership_role:14","subject_id":"alpha:company:9dca14ad-0c4d-46f4-acb9-dc2344fd2d5c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:srinivas-akkaraju-m-d-ph-d","object_label":"Srinivas Akkaraju, M.D., Ph.D.","object_source_name_forms":[],"value":"Srinivas Akkaraju, M.D., Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:srinivas-akkaraju-m-d-ph-d","name":"Srinivas Akkaraju, M.D., Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:16.622146+00:00","sources":[{"id":"alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Kalaris Therapeutics, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T23:29:01.172+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:16.622146+00:00","reviewed_at":"2026-10-16T13:53:16.622146+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:0120b480327eed18c22b2d41f629379ac2620a2de1a5ab01d55f793875a30064","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Kalaris Therapeutics, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T23:29:01.172+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.832,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.805,"cross_source_agreement":0.75,"temporal_completeness":0.727},"diagnostics":{"published_claims":20,"factual_claims":20,"claims_with_linked_evidence":20,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":11,"temporal_claims_with_valid_from":8,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","executive_role","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:53:16.622146+00:00","observed_at":"2026-10-16T13:53:16.622146+00:00","reviewed_at":"2026-10-16T13:53:16.622146+00:00","verified_at":"2026-10-16T13:53:16.622146+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":20,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/kalaris-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/kalaris-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}